Navigation Links
CryoCath to Hold Second Quarter 2008 Conference Call and Webcast
Date:5/1/2008 Toronto Stock Exchange Symbol: CYT

MONTREAL, May 1 /PRNewswire-FirstCall/ - CryoCath (TSX: CYT), will hold a conference call to discuss its second quarter 2008 financial results at 4:30 p.m. (Eastern Time) on Monday, May 12, 2008. The Company will report its results in a press release to be issued at 4:00 p.m. on Monday, May 12.

DATE: Monday, May 12, 2008

TIME: 4:30 p.m., Eastern Standard Time

TAPED REPLAY: 416-640-1917 or 1-877-289-8525

(Available until May 19, 2008)


WEBCAST: A live audio webcast of the call will be available at Webcast attendees are welcome to listen to

the conference in real-time or on-demand at their convenience.

The webcast will be archived for 365 days. Please connect to

this website at least 15 minutes prior to the conference call

to ensure adequate time for any software download that may be

needed to hear the webcast.

About CryoCath

CryoCath - - is a medical technology company that leads the world in cryotherapy products to treat cardiac arrhythmias. With a priority focus on providing physicians with a complete solution of catheter products to treat cardiac arrhythmias, CryoCath has multiple products approved in the U.S., across Europe and several ROW countries. The Company is developing additional products to expand its pipeline of products to treat cardiac arrhythmias.

This press release includes "forward-looking statements" that are subject to risks and uncertainties, including with respect to the timing of regulatory trials and their outcome. For information identifying legislative or regulatory, economic, climatic, currency, technological, competitive and other important factors that could cause actual results to differ materially from those anticipated in the forward looking statements, see CryoCath's annual report available at under the heading Risks and Uncertainties in the Management's Discussion and Analysis section.

SOURCE CryoCath Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. CryoCath Reports Data Presented at the 74th Annual Meeting of the German Cardiac Society
2. CryoCath Introduces Arctic Front in Australia
3. CryoCath Appoints New Chief Financial Officer
4. CryoCath Technologies notice of annual meeting
5. CryoCath Announces Fiscal 2008 First Quarter Results
6. CryoCath Provides Update on Patent Infringement Lawsuit
7. CryoCath to Hold First Quarter 2008 Conference Call and Webcast
8. CryoCath intends to contest patent infringement claim by CryoCor, Inc.
9. CryoCath announces 2007 fourth quarter and fiscal year end financial results
10. CryoCath to present at Piper Jaffray and BMO Healthcare conferences
11. CryoCath to present at CIBC Healthcare Conference
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... recently awarded their ... Eyeglasses . , Millions of individuals in the United States and Canada wear eyeglasses. ... way to both correct vision and make a fashion statement. Even celebrities use glasses ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
Breaking Medicine Technology: